BioNeutra Global Corporation
BGACF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $6 | $6 |
| - Cash | $2 | $1 | $1 | $1 |
| + Debt | $8 | $7 | $7 | $7 |
| Enterprise Value | $7 | $7 | $13 | $12 |
| Revenue | $11 | $13 | $15 | $24 |
| % Growth | -15% | -13.1% | -36.1% | – |
| Gross Profit | $4 | $2 | $3 | $4 |
| % Margin | 36.4% | 17.5% | 18.8% | 16.4% |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | -3.1% | -10.2% | -7.2% | -6.2% |
| Net Income | -$2 | -$3 | -$3 | -$4 |
| % Margin | -18.5% | -21.8% | -18.4% | -15.4% |
| EPS Diluted | -0.045 | -0.063 | -0.061 | -0.08 |
| % Growth | 27.8% | -3.3% | 23.7% | – |
| Operating Cash Flow | $1 | $1 | $0 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $1 | -$0 | $1 |